Investigating Bioequivalence Between Single-dose Liraglutide Administered Subcutaneously With Two Different Pen-injectors
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to investigate bioequivalence
between single-dose liraglutide administered subcutaneously with two different pen-injectors.